The document presents an overview of significant milestones in HIV/AIDS treatment and prevention, including FDA approvals of key medications from 1985 to 2012. It highlights the ongoing challenges faced by individuals living with HIV, particularly among the millennial generation aged 13-24, in terms of diagnosis, care retention, and viral suppression. Despite advancements, many are not fully benefiting from available treatments and resources.

2. my name is Adrienne

3. Reaching the Millennial
Generation about HIV/AIDS
Adrienne Chung
Senior Research Manager
Health Communications & Media Partnerships
Youth + Tech + Health Conference May 6, 2018

4. 1995: FDA approves the first
protease inhibitor, ushering in a
new era of highly active
antiretroviral therapy (HAART).20,000
64,900
130,400
84,800
48,700
58,400
56,300
38,500
1980 1985 1990 1995 2000 2005 2010 2015
41,800
1985: First HIV test licensed by FDA.
1987: FDA approves the first
antiretroviral drug for HIV (AZT).
2011: Study provides the first
evidence that ARVs also prevent HIV
transmission through sex.
2012: Truvada approved by the FDA
as PrEP, a daily pill to prevent HIV.
2010-2015: The CDC reports an
8% decrease in annual new HIV
infections over a five year period.
The Evolution of HIV in America
Multiple sources, including HIV Surveillance Report: Estimated HIV Incidence and Prevalence in the U.S., 2010-2015, CDC, reported
March 2018; HIV Timeline and History of Approvals, FDA, updated January 2018
Estimated Annual New HIV Infections in the U.S., 1980-2015

5. Yet many still are not benefiting from these
life-saving treatments, or even engaged in care
Of the 1.1 million people living with
HIV in the U.S., the percent who are…
Source: HIV Continuum of Care, U.S., 2014, CDC, reported July 2017
Among young people, ages 13-24, living
with HIV in the U.S., the percent who are…
56%
41%
31% 27%
Diagnosed Receiving
care
Retained in
care
Virally
suppressed
85%
62%
48% 49%
Diagnosed Receiving
care
Retained in
care
Virally
suppressed

6. 13-24
21%
25-34
34%
35-44
19%
45-54
15%
55+
10%
Source: HIV Surveillance Report: Diagnoses of HIV Infection in the U.S. and Dependent Areas, 2016, CDC, reported November 2017
13-24
21%
25-34
34%
35-44
19%
45-54
15%
55+
10%
13-34
55%
35-44
19%
45-54
15%
55+
10%
New HIV Diagnoses in the U.S. by Age, 2016

7. 9%
18%
12%
61%
U.S. Population
White
Black
Latino
Other
Sources: U.S. Census Population Distribution by Race/Ethnicity, 2016 ; HIV Surveillance Report: Diagnoses of HIV Infection in the U.S. and
Dependent Areas, 2016, CDC, reported November 2017
New HIV Diagnoses in the U.S. by Race, 2016
5%
25%
44%
26%
New HIV Diagnoses

8. National Survey of Young
Adults on HIV/AIDS
2017

14. 8 million+ video views (>:30)
10.2 million+ minutes viewed

15. 1.3 million+ video views (>:30)
over the past 12 months alone

16. 526,800+ people like our page

26. AdrienneC@kff.org